Dihydropyridine derivatives

Details Dihydropyridine derivatives Dihydropyridine derivatives

2007-07-24

2007-07-24

Morris, Patricia L. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S356000, C546S194000, C546S318000, C546S321000

Reexamination Certificate

active

10022874

ABSTRACT:
Compounds having a selective N-type calcium channel antagonistic activity are provided. Dihydropyridine derivatives represented by the following formula:analogs thereof and pharmaceutically acceptable salts thereof have an activity of selectively inhibiting the action of N-type calcium channel, and they are used as therapeutic agents for various diseases relating to N-type calcium channel.

REFERENCES:
patent: 4616002 (1986-10-01), Kamber et al.
patent: 5767131 (1998-06-01), Gluchowski et al.
patent: 6350762 (2002-02-01), Kito et al.
patent: 6350766 (2002-02-01), Uneyama et al.
patent: 0 520 200 (1992-12-01), None
patent: 0 622 364 (1994-11-01), None
patent: 0 705 819 (1996-04-01), None
patent: 0 985 667 (2000-03-01), None
patent: 1 043 314 (2000-10-01), None
patent: 60-233058 (1985-11-01), None
patent: 60233058 (1985-11-01), None
patent: 62-175462 (1987-08-01), None
patent: 08-041052 (1996-02-01), None
patent: WO 93/13128 (1993-07-01), None
patent: WO 94/22829 (1994-10-01), None
patent: WO 98/49144 (1998-11-01), None
patent: WO 99/32446 (1999-07-01), None
patent: WO 99/43658 (1999-09-01), None
patent: WO 00/24716 (2000-05-01), None
Virginia D. Monje et al.,A New Conus Peptide Ligand for Ca Channel Subtypes, Neuropharmacology,vol. 32, No. 11, pp. 1141-1149, 1993.
Hisayuki Uneyama et al.,Blockage of N-type Ca2+Current by Cilnidipine(FRC-8653)in Acutely Dissociated Rat Sympathetic Neurones, British Journal of Pharmacologyvol. 122, pp. 37-42, 1997.
Shigeo Fujii et al.,Effect of Cilnidipine, a Novel Dihydropyridine Ca++ -channel Antagonist, on N-type Ca++ Channel in Rat Dorsal Root Ganglion Neurons, The Journal of Pharmacology and Experimental Therapeutics,vol. 280, No. 3, pp. 1184-1191, 1997.
Sadanandam, Y. S., et al.,European J. of Med. Chem.,vol. 29, pp. 975-979 (1994).
Ramesh, M., et al.,J. Med. Chem.,vol. 41, pp. 509-514 (1998).
Brian Cox et al,Exp. Opin. Ther. Patents,“N-type calcium channel blockers in pain and stroke”, 1998, 8(10), pp. 1237-1250.
Peter R. Dodd et al, Neurochem. Int., “Excitotoxic Mechanisms in The Pathogenesis of Dementia”, 1994, vol. 25, No. 3, pp. 203-219.
Klaus W. Lange et al, Neuroscience and Biobehavioral Reviews, “Dopamine/Glutamate Interactions in Parkinson's Disease”, 1997, vol. 21, No. 4, pp. 393-400.
Karl D. Kieburtz et al, Arch. Neurol., “Excitotoxicity and Dopaminergic Dysfunction in the Acquired Immunodeficiency Syndrome Dementia Complex”, Dec. 1991, vol. 48, pp. 1281-1284.
Toshio Imaizumi et al, Brain Research, “The role of voltage-gated Ca2+channels in anoxic injury of spinal cord white matter”, 1999, vol. 817, pp. 84-92.
Ken P. Madden et al, Brain Research, “Treatment with conotoxin, an ‘N-type’ calcium channel blocker, in neuronal hypoxic-ischemic injury”, vol. 537, 1990, pp. 256-262.
D. M. White et al, Brain Research, “Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia”, 1998, vol. 801, pp. 50-58.
Laura Basilico et al, European Journal of Pharmacology, “Influence of ω-conotoxin on morphine analgesia and withdrawal syndrome in rates”, 1992, vol. 218, pp. 75-81.
R.C. Pierce et al, The Journal of Pharmacology Experimental Therapeutics, “Calcium-Mediated Second Messengers Modulate the Expression of Behavioral Sensitization to Cocaine”, 1998, vol. 286, No. 3, pp. 1171-1176.
Kazuyuki Murase et al, Brain Research, “Serotonin suppressesN-methyl-D-aspartate responses in acutely isolated spinal dorsal horn neurons of the rat”, vol. 525, 1990, pp. 84-91.
Dhanapalan Nagarathnam et al, J. Med. Chem., “Design and Synthesis of Novel α1aAdrenoceptor-Selective Dihydropyridine Antagonists for the Treatment of Benign Prostatic Hyperplasia”, vol. 41, 1998, pp. 5320-5333.
Wai C. Wong et al, J. Med. Chem., “Identification of a Dihydropyridine as a Potent α1aAdrenoceptor Selective Antagonist That Inhibits Phenylephrine-Induced Contraction of the Human Prostate”, vol. 41, 1998, pp. 2643-2650.
J. B. Sainani et al, Indian Journal of Chemistry, “Formation of 1,4,5,6,7,8-hexahydro-pyrido[4,3-b]pyridine by Hantzsch synthesis”, vol. 34B, Jan. 1995, pp. 17-20.

Affiliated with

Also associated with

Rating

Dihydropyridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dihydropyridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydropyridine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3793515